BI 831266

BI-831266 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 831266, covering 2013-11-21 to 2013-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of BI 831266 in Patients With Advanced Solid Tumours [Phase 1]